A DELPHI study on aspects of study design to overcome knowledge gaps on the burden of disease caused by serogroup B invasive meningococcal disease
Ole Marten(Bielefeld University), Wolfgang Greiner(Bielefeld University), Nicolas Van de Velde(GlaxoSmithKline (Belgium)), Philipp Henneke(Brigham and Women's Hospital), Markus Knuf(Helios Kliniken), R Welte(GlaxoSmithKline (Germany)), A Monteiro(University of Illinois Chicago), Monika Bullinger(Zimmer Biomet (Germany)), Philippe De Wals(Université Laval), Joseph Patrick Sevilla(Health Decisions (United States)), David E. Bloom(Harvard University), Florian Koerber(MorphoSys (Germany)), Burkhard Lawrenz(Berufsverband der Frauenärzte), Claire Wright(Meningitis Research Foundation), Hannah Christensen(University of Bristol), Christian Dohna‐Schwake(Essen University Hospital), Corinne Buysse(Erasmus MC - Sophia Children’s Hospital), Markus Kirchner(Banco Central de Chile)
Cited by 11
Related Papers
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
|JNCI Journal of the National Cancer Institute|1993|15.9k
Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries
|Journal of Clinical Epidemiology|1998|2.9k
The Global Economic Burden of Noncommunicable Diseases
|WU Research|2012|2k
Barriers and Strategies in Guideline Implementation—A Scoping Review
|Healthcare|2016|946
Translating Health Status Questionnaires and Evaluating Their Quality
|Journal of Clinical Epidemiology|1998|921